Welcome to our dedicated page for Transcat news (Ticker: TRNS), a resource for investors and traders seeking the latest updates and insights on Transcat stock.
Transcat Inc (TRNS) provides essential calibration services and compliance solutions for life sciences, pharmaceutical, and industrial sectors. This news hub offers investors and industry professionals direct access to official corporate announcements and strategic developments.
Find timely updates on regulatory compliance achievements, service network expansions, and financial performance. Our curated collection includes earnings reports, instrumentation innovations, and quality assurance milestones that demonstrate Transcat's market leadership.
Key content areas cover FDA-related compliance updates, ISO/IEC 17025 accreditation developments, distribution partnerships, and operational enhancements across Transcat's North American service centers. All materials maintain strict adherence to factual reporting standards.
Bookmark this page for streamlined access to Transcat's verified announcements. Check regularly for updates impacting measurement services, laboratory instrument validation, and industrial compliance solutions in regulated markets.
Transcat (NASDAQ:TRNS) reported strong fiscal Q1 2026 results with significant growth across key metrics. The company achieved consolidated revenue of $76.4 million, up 14.6% year-over-year, with Service revenue increasing 12.3% to $49.1 million and Distribution revenue growing 19% to $27.3 million.
The company's Adjusted EBITDA rose 15.2% to $11.8 million, while Distribution segment achieved record gross margins of 35.2%. Notably, Transcat announced the acquisition of Essco Calibration Laboratory, their largest deal to date, which adds $22 million in annual revenue and strengthens their presence in the New England market.
To support growth initiatives, Transcat secured a new 5-Year $150 Million syndicated credit facility, nearly doubling their previous capacity. The company maintains a strong balance sheet with a 0.82x leverage ratio and expects high single-digit organic revenue growth in the second half of fiscal 2026.
Transcat (NASDAQ: TRNS) has completed its largest-ever acquisition, purchasing Essco Calibration Laboratory for $84 million in cash. Essco, an ISO-17025 Accredited calibration laboratory based in the Boston metro area, generates over $22 million in annual revenue with EBITDA margins exceeding 25%.
The strategic acquisition positions Transcat as the dominant player in New England's calibration services market. Essco brings 113 employees and serves various sectors including Medical, Life Science, Aerospace & Defense, and Industrial. The deal was financed through Transcat's new $150 million syndicated credit facility led by M&T Bank and Wells Fargo Bank.
This acquisition follows Transcat's purchase of Martin Calibration in December, with both deals expected to contribute approximately $50 million in annualized revenue focused on core calibration services.
Transcat (NASDAQ: TRNS), a leader in test measurement, control and calibration, has secured a new $150 million syndicated secured credit facility with a 5-year term. The facility is led by M&T Bank and includes Wells Fargo and Bank of America as additional lenders.
The new credit facility, which replaces an existing $80 million facility, includes revolving loan options, swingline loans, and letters of credit. It features enhanced flexibility with a temporary leverage ratio covenant increase for permitted acquisitions. The facility will be used to refinance the previous facility, fund strategic acquisitions, and provide working capital for general corporate purposes.
Transcat (Nasdaq: TRNS), a leader in test measurement, control and calibration, has scheduled its first quarter fiscal year 2026 earnings conference call for Thursday, August 7, 2025, at 11:00 a.m. ET. The company will release its financial results after market close on Wednesday, August 6, 2025.
The conference call will include a discussion of the company's financial results, corporate strategy, and outlook, followed by a Q&A session. Participants can join via toll-free number (800) 267-6316 or international number (203) 518-9783 using Conference ID: TRANSCAT. A webcast replay will be available until August 14, 2025.
Transcat Inc. (NASDAQ: TRNS), a provider of calibration services and professional test equipment, has announced its participation in the 22nd Annual Craig-Hallum Institutional Investor Conference. The event will take place on May 28, 2025, at the Depot Renaissance Hotel in Minneapolis, Minnesota.
The company's leadership team, including CEO Lee Rudow, CFO Tom Barbato, and COO Mike West, will be available for one-on-one and small group meetings with investors throughout the conference. Interested parties can schedule meetings through their Craig-Hallum representative or by contacting TRNS@mzgroup.us.
Transcat (Nasdaq: TRNS), a provider of calibration services and test equipment, has scheduled its fourth quarter fiscal year 2025 earnings release for Monday, May 19, 2025, after market close. The company will host a conference call and webcast on Tuesday, May 20, 2025, at 11:00 a.m. Eastern Time to discuss financial results and corporate strategy.
Investors can access the call via phone at (201) 689-8471 or through the webcast on Transcat's investor relations website. A replay will be available until May 27, 2025, by dialing (412) 317-6671 with conference ID 13753614, or through the company's website where a transcript will also be posted.
Transcat (NASDAQ: TRNS), a provider of calibration services and test equipment distribution, has engaged MZ Group for strategic investor relations services. The company reported strong financial performance with Q3 2025 revenue of $66.8 million and FY 2024 revenue growth of 13% to $259.5 million. Notable achievements include:
- 63 consecutive quarters of Service segment revenue growth - FY 2024 gross margin of 34% - FY 2024 Adjusted EBITDA of $38.6 million - Net income up 28% to $13.6 million - Operating free cash flow of $19.3 million - Low leverage ratio of 0.97 with $40.5 million available credit
The company's recent Martin Calibration acquisition strengthens its Midwest presence in life sciences and aerospace/defense markets. The global calibration services market is projected to reach $8.1 billion by 2030, driven by regulatory standards and increased manufacturing automation.
FAQ
What is the current stock price of Transcat (TRNS)?
What is the market cap of Transcat (TRNS)?
